Adjuvant and Neoadjuvant Therapy for Colorectal Cancer: Molecular-Based Therapy - ScienceDirect
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic. - ppt video online download
CAPOX - Wikipedia
Kaplan–Meier curves of patients with stage III colon cancer in right-... | Download Scientific Diagram
PDF) PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea | Sang-Yhun Ju - Academia.edu
The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
Colorectal Cancer: Postoperative Adjuvant Therapy and Surveillance | SpringerLink
4019-Adjuvant CAPOX (XELOX) (capecitabine and oxaliplatin) | eviQ
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Gastrointestinal cancers: new standards of care from landmark trials | MDedge Hematology and Oncology
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Proposed decision algorithm for adjuvant therapy in colon cancer LN:... | Download Scientific Diagram
Table 1 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Adjuvant Therapy for Early Colon Cancer | Drugs
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. | Semantic Scholar
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Author: Eman Sobhy Elbanna/ Title: Adjuvant short XELOX followed by capecitabine for stage III colon cancer :
